Media Contact
Have media inquiries? Contact us.
Director, Marketing Communications
The Coronavirus (Covid-19) and You...
The Leukemia & Lymphoma Society of Canada is closely monitoring the developments on the coronavirus disease (COVID-19) outbreak and how it might impact Canadians affected by blood cancers. Visit our COVID-19 Resource Center Some people in treatment may be worried about the supply of therapeutic drugs (such as Imbruvica or Ibrutinib) produced in China. Its manufacturer Pharmacyclics is closely monitoring the...
Save more lives this #GivingTuesday
A blood cancer diagnosis can feel overwhelming.
Thanks to your support, one thing patients and their loved ones never have to worry about is the behind-the-scenes work of researchers across the country.
Whether scientists are exploring the underlying cause of blood cancers or new treatment options, we’re making progress on so many fronts.
And it’s all because of you.
CAR T-cell therapy now available in Quebec
Children and young adults with acute lymphoblastic leukemia (ALL) and adults with diffuse large B-cell lymphoma (BCGLD) who have not responded to standard treatments will be able to take advantage of CAR T-Cell Therapy. Two facilities offer this treatment: the Sainte-Justine University Hospital Center (CHU Sainte-Justine), for children, and the Maisonneuve-Rosemont Hospital (HMR) of the CIUSSS Eas...
National Leukemia Conference 2019
VANCOUVER, BC (November 9, 2019) – The Leukemia & Lymphoma Society of Canada (LLSC) will bring together leading experts, patients and survivors on Saturday, November 9th during a day-long conference. The National Leukemia Conference – first of its kind in Canada – will showcase the breadth and excellence of Canadian blood cancer research, and enhance patient involvement and education. “Leukem...